Affinity Asset Advisors’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.45M | Hold |
|
|||||
|
2025
Q1 | $5.26M | Buy |
|
|||||
|
2024
Q4 | $3.06M | Sell |
|
|||||
|
2024
Q3 | $11.9M | Buy |
|
|||||
|
2024
Q2 | $1.95M | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $1.09M | Buy |
|
|||||
|
2023
Q3 | – | Hold |
|
|||||
|
2023
Q2 | – | Hold |
|
|||||
|
2023
Q1 | – | Hold |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $239K | Sell |
|
|||||
|
2022
Q1 | $925K | Buy |
|